{"id":"https://openalex.org/W1985020104","doi":"https://doi.org/10.1097/01.jcp.0000203200.96205.34","title":"Risk Factors for Extrapyramidal Symptoms During Treatment With Selective Serotonin Reuptake Inhibitors, Including Cytochrome P-450 Enzyme, and Serotonin and Dopamine Transporter and Receptor Polymorphisms","display_name":"Risk Factors for Extrapyramidal Symptoms During Treatment With Selective Serotonin Reuptake Inhibitors, Including Cytochrome P-450 Enzyme, and Serotonin and Dopamine Transporter and Receptor Polymorphisms","alternate_titles":[],"publication_year":2006,"publication_date":"2006-04-01","ids":{"openalex":"https://openalex.org/W1985020104","doi":"https://doi.org/10.1097/01.jcp.0000203200.96205.34","mag":"1985020104","pmid":"https://pubmed.ncbi.nlm.nih.gov/16633151"},"language":"en","primary_location":{"id":"doi:10.1097/01.jcp.0000203200.96205.34","doi":"https://doi.org/10.1097/01.jcp.0000203200.96205.34","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.jcp.0000203200.96205.34","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1985020104"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000303989","display_name":"Karin Hedenmalm","orcid":"https://orcid.org/0000-0002-9544-9163","observed_orcids":["https://orcid.org/0000-0002-9544-9163"]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]},{"id":"https://openalex.org/I1319126558","display_name":"Medical Products Agency","ror":"https://ror.org/0356c4a29","country_code":"SE","type":"government","lineage":["https://openalex.org/I1319126558"]}],"countries":["SE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Karin Hedenmalm","raw_affiliation_strings":["Clinical Trial Unit, Medical Products Agency, Uppsala, Sweden. karin.hedenmalm@mpa.se","Clinical Trial Unit, Medical Products Agency, Uppsala, Sweden","Department of Medical Sciences, Clinical Pharmacology, Uppsala University, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Trial Unit, Medical Products Agency, Uppsala, Sweden. karin.hedenmalm@mpa.se","institution_ids":["https://openalex.org/I1319126558"]},{"raw_affiliation_string":"Clinical Trial Unit, Medical Products Agency, Uppsala, Sweden","institution_ids":["https://openalex.org/I1319126558"]},{"raw_affiliation_string":"Department of Medical Sciences, Clinical Pharmacology, Uppsala University, Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009977721","display_name":"C\u00fcneyt G\u00fczey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204778367","display_name":"Norwegian University of Science and Technology","ror":"https://ror.org/05xg72x27","country_code":"NO","type":"education","lineage":["https://openalex.org/I204778367"]},{"id":"https://openalex.org/I4210104358","display_name":"St Olav's University Hospital","ror":"https://ror.org/01a4hbq44","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I4210104358"]}],"countries":["NO"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C\u00fcneyt G\u00fczey","raw_affiliation_strings":["Department of Clinical Pharmacology, St Olav University Hospital and Norwegian University of Science and Technology, Trondheim, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, St Olav University Hospital and Norwegian University of Science and Technology, Trondheim, Norway","institution_ids":["https://openalex.org/I204778367","https://openalex.org/I4210104358"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001100678","display_name":"Marja\u2010Liisa Dahl","orcid":"https://orcid.org/0000-0002-4837-6299","observed_orcids":["https://orcid.org/0000-0002-4837-6299"]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marja-Liisa Dahl","raw_affiliation_strings":["Department of Medical Sciences, Clinical Pharmacology, Uppsala University, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Sciences, Clinical Pharmacology, Uppsala University, Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066812926","display_name":"Qun\u2010Ying Yue","orcid":"https://orcid.org/0000-0003-2475-2621","observed_orcids":["https://orcid.org/0000-0003-2475-2621"]},"institutions":[{"id":"https://openalex.org/I1319126558","display_name":"Medical Products Agency","ror":"https://ror.org/0356c4a29","country_code":"SE","type":"government","lineage":["https://openalex.org/I1319126558"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Qun-Ying Yue","raw_affiliation_strings":["Pharmacovigilance Unit, Medical Products Agency, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacovigilance Unit, Medical Products Agency, Uppsala, Sweden","institution_ids":["https://openalex.org/I1319126558"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031025442","display_name":"Olav Spigset","orcid":"https://orcid.org/0000-0001-7902-9014","observed_orcids":["https://orcid.org/0000-0001-7902-9014"]},"institutions":[{"id":"https://openalex.org/I204778367","display_name":"Norwegian University of Science and Technology","ror":"https://ror.org/05xg72x27","country_code":"NO","type":"education","lineage":["https://openalex.org/I204778367"]},{"id":"https://openalex.org/I4210104358","display_name":"St Olav's University Hospital","ror":"https://ror.org/01a4hbq44","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I4210104358"]}],"countries":["NO"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Olav Spigset","raw_affiliation_strings":["Department of Clinical Pharmacology, St Olav University Hospital and Norwegian University of Science and Technology, Trondheim, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, St Olav University Hospital and Norwegian University of Science and Technology, Trondheim, Norway","institution_ids":["https://openalex.org/I204778367","https://openalex.org/I4210104358"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5000303989"],"corresponding_institution_ids":["https://openalex.org/I123387679","https://openalex.org/I1319126558"],"apc_list":null,"apc_paid":null,"fwci":5.4517,"has_fulltext":false,"cited_by_count":92,"citation_normalized_percentile":{"value":0.96503606,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"26","issue":"2","first_page":"192","last_page":"197"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.48510000109672546,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.48510000109672546,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.3422999978065491,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.07339999824762344,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/extrapyramidal-symptoms","display_name":"extrapyramidal symptoms","score":1.0},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.996999979019165},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.9419999718666077},{"id":"https://openalex.org/keywords/genetic-polymorphism","display_name":"genetic polymorphism","score":0.7730000019073486},{"id":"https://openalex.org/keywords/cytochrome-p450","display_name":"cytochrome P450","score":0.8889999985694885},{"id":"https://openalex.org/keywords/serotonin-transporter","display_name":"serotonin transporter","score":0.6489999890327454},{"id":"https://openalex.org/keywords/dopamine-transporter","display_name":"dopamine transporter","score":0.9909999966621399},{"id":"https://openalex.org/keywords/dopamine-d2-receptor","display_name":"dopamine D2 receptor","score":0.8460000157356262},{"id":"https://openalex.org/keywords/risk-factors","display_name":"risk factors","score":0.7910000085830688},{"id":"https://openalex.org/keywords/age","display_name":"age","score":0.4950000047683716},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.6650000214576721},{"id":"https://openalex.org/keywords/spontaneous-adverse-drug-reports","display_name":"spontaneous adverse drug reports","score":0.5799999833106995}],"concepts":[{"id":"https://openalex.org/C2778897192","wikidata":"https://www.wikidata.org/wiki/Q410142","display_name":"Serotonin transporter","level":4,"score":0.6982948780059814},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5010991096496582},{"id":"https://openalex.org/C2780616385","wikidata":"https://www.wikidata.org/wiki/Q1385411","display_name":"Extrapyramidal symptoms","level":4,"score":0.4814026355743408},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.461539089679718},{"id":"https://openalex.org/C37000724","wikidata":"https://www.wikidata.org/wiki/Q50430226","display_name":"Serotonergic","level":4,"score":0.45968174934387207},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.45908322930336},{"id":"https://openalex.org/C199596767","wikidata":"https://www.wikidata.org/wiki/Q21110872","display_name":"Dopamine receptor D3","level":4,"score":0.4100360870361328},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.39352452754974365},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.38966628909111023},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.38402339816093445},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.37742748856544495},{"id":"https://openalex.org/C44208683","wikidata":"https://www.wikidata.org/wiki/Q15335165","display_name":"Dopamine receptor D2","level":3,"score":0.3700217604637146},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.33739134669303894},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.2787492871284485},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.13646456599235535}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000367","descriptor_name":"Age Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000437","descriptor_name":"Alcoholism","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D001480","descriptor_name":"Basal Ganglia Diseases","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D001480","descriptor_name":"Basal Ganglia Diseases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D003577","descriptor_name":"Cytochrome P-450 Enzyme System","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005787","descriptor_name":"Gene Frequency","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011110","descriptor_name":"Polymorphism, Genetic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013548","descriptor_name":"Sweden","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D017448","descriptor_name":"Receptors, Dopamine D2","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D020022","descriptor_name":"Genetic Predisposition to Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D050483","descriptor_name":"Dopamine Plasma Membrane Transport Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D050486","descriptor_name":"Serotonin Plasma Membrane Transport Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/01.jcp.0000203200.96205.34","doi":"https://doi.org/10.1097/01.jcp.0000203200.96205.34","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.jcp.0000203200.96205.34","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:16633151","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16633151","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical psychopharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320322581","display_name":"Vetenskapsr\u00e5det","ror":"https://ror.org/03zttf063"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":43,"referenced_works":["https://openalex.org/W23893323","https://openalex.org/W28790285","https://openalex.org/W1608407352","https://openalex.org/W1766115599","https://openalex.org/W1971923388","https://openalex.org/W1973698869","https://openalex.org/W1975261575","https://openalex.org/W1981684805","https://openalex.org/W1986019200","https://openalex.org/W1986637546","https://openalex.org/W1995006301","https://openalex.org/W1995762908","https://openalex.org/W1996673522","https://openalex.org/W2013349550","https://openalex.org/W2018675282","https://openalex.org/W2019573888","https://openalex.org/W2020371172","https://openalex.org/W2035975036","https://openalex.org/W2038444868","https://openalex.org/W2044494092","https://openalex.org/W2045530950","https://openalex.org/W2049377642","https://openalex.org/W2053730389","https://openalex.org/W2055772637","https://openalex.org/W2059997499","https://openalex.org/W2063456354","https://openalex.org/W2065886257","https://openalex.org/W2066080149","https://openalex.org/W2069152617","https://openalex.org/W2074021723","https://openalex.org/W2083944558","https://openalex.org/W2103398163","https://openalex.org/W2104431145","https://openalex.org/W2136547837","https://openalex.org/W2136825478","https://openalex.org/W2146220657","https://openalex.org/W2153640583","https://openalex.org/W2156412357","https://openalex.org/W2288991238","https://openalex.org/W2324098239","https://openalex.org/W2334233500","https://openalex.org/W2399277565","https://openalex.org/W4243436463"],"related_works":["https://openalex.org/W2103398163","https://openalex.org/W2007029624","https://openalex.org/W2098785067","https://openalex.org/W1996673522","https://openalex.org/W1995006301","https://openalex.org/W1987089618","https://openalex.org/W2076270748","https://openalex.org/W3133192489","https://openalex.org/W2032217892","https://openalex.org/W174697142"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Extrapyramidal":[1],"symptoms":[2],"(EPS)":[3],"are":[4],"rare":[5],"adverse":[6,45],"drug":[7,46,204],"reactions":[8],"to":[9,18,66,72,239,270,320],"selective":[10],"serotonin":[11,36,133],"reuptake":[12],"inhibitors":[13],"(SSRIs).":[14],"This":[15],"study":[16,295],"aimed":[17],"investigate":[19],"the":[20,51,78,173,176,180,260,277,280,289,297,313],"potential":[21,162,214,336],"risk":[22,163,215,264,337],"factors":[23,164],"for":[24,85,126,202,217],"EPS":[25,63,147,266,309],"associated":[26],"with":[27,62,244,267,272,276],"SSRIs":[28,96,268,311],"including":[29,90],"polymorphisms":[30],"of":[31,87,95,109,117,128,143,146,167,175,179,223,253,259,265,279,283,288,293,299],"cytochrome":[32,130],"P-450":[33],"isoenzymes,":[34],"and":[35,37,40,64,92,97,113,132,134,137,155,172,275,296,318],"dopamine":[38,135,182],"transporters":[39],"receptors.":[41],"METHODS:":[42],"All":[43],"spontaneous":[44],"reaction":[47],"reports":[48],"received":[49,82],"by":[50],"Swedish":[52],"Medical":[53],"Products":[54],"Agency":[55],"until":[56],"December":[57],"1999":[58],"that":[59],"were":[60,75,148,153,159],"coded":[61],"judged":[65],"be":[67,321,330],"at":[68],"least":[69,211,333],"possibly":[70],"related":[71],"SSRI":[73],"treatment":[74,243],"included":[76,165],"in":[77,257,323,341],"study.":[79],"Reporting":[80],"physicians":[81],"a":[83,107,114,221,251],"form":[84],"collection":[86],"relevant":[88],"information":[89],"current":[91,237],"previous":[93,235],"use":[94,298],"antipsychotics,":[98],"alcohol":[99,228],"or":[100,111,170,206,229,236,247,250],"substance":[101,230],"abuse,":[102,231],"central":[103,224],"nervous":[104,225],"system":[105,226],"damage,":[106,227],"history":[108,116,222,252],"epilepsy":[110],"EPS,":[112,218,254],"family":[115],"Parkinson":[118,233],"disease.":[119],"A":[120,141],"blood":[121,157],"sample":[122,291],"was":[123,200,255,339],"also":[124],"requested":[125],"genotyping":[127],"selected":[129],"P-450,":[131],"transporter":[136],"receptor":[138,183],"mutations.":[139],"RESULTS:":[140],"total":[142],"64":[144],"cases":[145],"reported.":[149],"Twenty-eight":[150],"forms":[151],"(46%)":[152],"returned,":[154],"20":[156],"samples":[158],"obtained.":[160],"Identified":[161],"age":[166,274],"65":[168],"years":[169],"older":[171],"presence":[174,278],"A1":[177,281],"allele":[178,282],"D2":[181],"gene":[184],"(DRD2)":[185],"Taq1A":[186,285],"polymorphism":[187],"(relative":[188],"risk,":[189],"2.4;":[190],"95%":[191],"confidence":[192],"interval,":[193],"1.2-4.5":[194],"vs":[195],"literature":[196],"controls).":[197],"No":[198],"relationship":[199],"apparent":[201],"sex,":[203],"dose,":[205],"other":[207,245,324],"genetic":[208],"polymorphisms.":[209],"At":[210,332],"1":[212,334],"additional":[213,335],"factor":[216,338],"such":[219],"as":[220],"epilepsy,":[232],"disease,":[234],"exposure":[238],"antipsychotic":[240],"drugs,":[241],"concomitant":[242],"antidopaminergic":[246],"serotonergic":[248],"agents,":[249],"found":[256,340],"93%":[258],"cases.":[261,344],"CONCLUSION:":[262],"The":[263],"seems":[269],"increase":[271],"advanced":[273],"DRD2":[284,314],"polymorphism.":[286],"Because":[287],"small":[290],"size":[292],"our":[294],"historical":[300],"controls":[301],"rather":[302],"than":[303],"patients":[304],"who":[305],"did":[306],"not":[307],"experience":[308],"during":[310],"treatment,":[312],"finding":[315],"is":[316],"preliminary":[317],"needs":[319],"replicated":[322],"studies":[325],"before":[326],"firm":[327],"conclusions":[328],"can":[329],"drawn.":[331],"almost":[342],"all":[343]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1985020104","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
